These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2555536)

  • 1. Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells.
    Haddad RS; Hutt-Fletcher LM
    J Virol; 1989 Dec; 63(12):4998-5005. PubMed ID: 2555536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus.
    Miller N; Hutt-Fletcher LM
    J Virol; 1988 Jul; 62(7):2366-72. PubMed ID: 2836619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the Epstein-Barr virus envelope fusion glycoprotein gp85 gene by a recombinant baculovirus.
    Pulford D; Lowrey P; Morgan AJ
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3241-8. PubMed ID: 7525863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying gp85-regions involved in Epstein-Barr virus binding to B-lymphocytes.
    Urquiza M; Suarez J; Lopez R; Vega E; Patino H; Garcia J; Patarroyo MA; Guzman F; Patarroyo ME
    Biochem Biophys Res Commun; 2004 Jun; 319(1):221-9. PubMed ID: 15158465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein.
    Yaswen LR; Stephens EB; Davenport LC; Hutt-Fletcher LM
    Virology; 1993 Aug; 195(2):387-96. PubMed ID: 8393232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells.
    Oda T; Imai S; Chiba S; Takada K
    Virology; 2000 Oct; 276(1):52-8. PubMed ID: 11021994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Epstein-Barr virus (EBV) receptors expression on various human lymphoid targets and their significance to EBV-cell interaction.
    Stocco R; Sauvageau G; Menezes J
    Virus Res; 1988 Oct; 11(3):209-25. PubMed ID: 2848382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus enters B cells and epithelial cells by different routes.
    Miller N; Hutt-Fletcher LM
    J Virol; 1992 Jun; 66(6):3409-14. PubMed ID: 1316456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus infectivity of Raji and Molt 4 cells: differences in cellular membrane lipids and apparent microviscosity.
    Patel RA; Hutt-Fletcher LM; Crews FT
    Virology; 1993 Jul; 195(1):121-31. PubMed ID: 8391180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame.
    Oba DE; Hutt-Fletcher LM
    J Virol; 1988 Apr; 62(4):1108-14. PubMed ID: 2831373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.
    Nemerow GR; Mold C; Schwend VK; Tollefson V; Cooper NR
    J Virol; 1987 May; 61(5):1416-20. PubMed ID: 3033269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding to cells of virosomes containing herpes simplex virus type 1 glycoproteins and evidence for fusion.
    Johnson DC; Wittels M; Spear PG
    J Virol; 1984 Oct; 52(1):238-47. PubMed ID: 6090699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF; Goldmacher VS; Lambert JM; Schlossman SF
    J Immunol; 1986 Aug; 137(4):1387-91. PubMed ID: 3016095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytes.
    Sauvageau G; Stocco R; Kasparian S; Menezes J
    J Gen Virol; 1990 Feb; 71 ( Pt 2)():379-86. PubMed ID: 2155291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sendai virus envelopes can mediate Epstein-Barr virus binding to and penetration into Epstein-Barr virus receptor-negative cells.
    Khélifa R; Menezes J
    J Virol; 1983 Apr; 46(1):325-32. PubMed ID: 6298467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of fluoresceinated Epstein-Barr virus to study Epstein-Barr virus-lymphoid cell interactions.
    Khelifa R; Menezes J
    J Virol; 1982 Feb; 41(2):649-56. PubMed ID: 6281475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of the purified Epstein Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligand binding functions.
    Mold C; Cooper NR; Nemerow GR
    J Immunol; 1986 Jun; 136(11):4140-5. PubMed ID: 3009615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor.
    Haan KM; Kwok WW; Longnecker R; Speck P
    J Virol; 2000 Mar; 74(5):2451-4. PubMed ID: 10666279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional association of class II antigens with cell surface binding of Epstein-Barr virus.
    Reisert PS; Spiro RC; Townsend PL; Stanford SA; Sairenji T; Humphreys RE
    J Immunol; 1985 Jun; 134(6):3776-80. PubMed ID: 2985696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells.
    Li Q; Turk SM; Hutt-Fletcher LM
    J Virol; 1995 Jul; 69(7):3987-94. PubMed ID: 7539502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.